Tocilizumab in patients with Systemic Juvenile Idiopathic Arthritis (sJIA): 12-week Pharmacokinetic (PK) and Pharmacodynamic (PD) data from the Phase 3 TENDER Trial

被引：0
|
作者：
Ruperto, N. [1 ]
Zhang, A.
Morcos, P. N.
Huppertz, H. [1 ]
Minden, K. [1 ]
Myones, B. [1 ]
Onel, K. [1 ]
Siammopoulou, A. [1 ]
Silva, C. [1 ]
Kenwright, A.
Roseti, S.
De Benedetti, F. [2 ]
Lovell, D. [1 ]
Martini, A. [1 ]
Brunner, H. [1 ]
机构：
[1] IRCCS G Gaslini Pediatria II, Reumatol PRINTO, Genoa, Italy
[2] Bambin Gesu Rome, Rome, Italy
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2011年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：421 / 421
页数：1
相关论文
共 50 条
  • [31] CATCH-UP GROWTH DURING TOCILIZUMAB THERAPY FOR SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 2-YEAR DATA FROM A PHASE 3 CLINICAL TRIAL
    De Benedetti, F.
    Ruperto, N.
    Espada, G.
    Gerloni, V.
    Flato, B.
    Horneff, G.
    Myones, B.
    Onel, K.
    Frane, J.
    Wang, J.
    Lipman, T.
    Bharucha, K.
    Martini, A.
    Lovell, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 729 - 730
  • [32] Catch-up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase 3 Clinical Trial.
    De Benedetti, Fabrizio
    Ruperto, Nicolino
    Espada, Graciela
    Gerloni, Valeria
    Flato, Berit
    Horneff, Gerd
    Myones, Barry L.
    Onel, Karen
    Frane, James
    Kenwright, Andrew
    Lipman, Terri H.
    Bharucha, Kamal N.
    Martini, Alberto
    Lovell, D. J.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S327 - S327
  • [33] Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis Results From a Phase III Trial
    De Benedetti, Fabrizio
    Brunner, Hermine
    Ruperto, Nicolino
    Schneider, Rayfel
    Xavier, Ricardo
    Allen, Roger
    Brown, Diane E.
    Chaitow, Jeffrey
    Pardeo, Manuela
    Espada, Graciela
    Gerloni, Valeria
    Myones, Barry L.
    Frane, James W.
    Wang, Jianmei
    Lipman, Terri H.
    Bharucha, Kamal N.
    Martini, Alberto
    Lovell, Daniel
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67 (03) : 840 - 848
  • [34] Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martini, Alberto
    Lovell, Daniel
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 64 - 66
  • [35] DISABILITY AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL
    Ruperto, Nicolino
    Chen, Chen
    Martini, Alberto
    Espada, Graciela
    Joos, Rik
    Akikusa, Jonathan
    Chaitow, Jeffrey
    Gamir, Maria Luz Gamir
    Kimura, Yukiko
    Rietschel, Christoph
    Siri, Daniel
    Smolewska, Elzbieta
    Schmeling, Heinrike
    Brown, Diane
    De Benedetti, Fabrizio
    Lovell, Daniel J.
    Huang, Bin
    Brunner, Hermine
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 981 - 982
  • [36] Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis Patients Treated with Canakinumab: Results from Phase 3 Trial Program
    Grom, Alexei A.
    Brunner, Hermine I.
    Ruperto, Nicolino
    Martini, Alberto
    Lovell, Daniel
    Pascual, Virginia
    Lheritier, Karine
    Leon, Karolynn
    Abrams, Ken
    Ilowite, Norman
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [37] Long-Term Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results from a PHASE III Extension Study
    Brunner, Hermine I.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin', Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martinis, Alberto
    Lovell, Daniel J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [38] EVALUATION OF EFFICACY AND SAFETY OF CANAKINUMAB IN JAPANESE PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN PHASE III CLINICAL TRIAL, COMPOSED PREDOMINANTLY OF PATIENTS WITH PRIOR USE OF TOCILIZUMAB
    Takei, S.
    Hara, R.
    Umebayashi, H.
    Iwata, N.
    Imagawa, T.
    Shimizu, M.
    Tomiita, M.
    Seko, N.
    Kitawaki, T.
    Wang, G.
    Yokota, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 499 - 500
  • [39] GROWTH DURING TOCILIZUMAB THERAPY IN PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS: 2-YEAR DATA FROM THE PHASE III CHERISH TRIAL
    Ramanan, Athimalaipet
    Bharucha, Kamal N.
    Brunner, Hermine I.
    Ruperto, Nicola
    Cabral, David A.
    Gedalia, Abraham
    Gerloni, Valeria
    Jorgensen, Christian
    Lovell, Daniel J.
    Martini, Alberto
    Frane, Jim
    Wells, Chris
    De Benedetti, Fabrizio
    [J]. RHEUMATOLOGY, 2015, 54 : 157 - 158
  • [40] Growth during Tocilizumab Therapy for Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data from a Phase 3 Clinical Trial.
    Bharucha, Kamal N.
    Brunner, Hermine I.
    Ruperto, Nicola
    Cabral, David A.
    Gedalia, Abraham
    Gerloni, Valeria
    Jorgensen, Christian
    Ramanan, Athimalaipet
    Lovell, Daniel
    Martini, Alberto
    Frane, James
    Wells, Chris
    De Benedetti, Fabrizio, Sr.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S117 - S117
12345